Liquid Biospy for Urinary Cancers

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

NCT02745301 ·Status: COMPLETED

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

NCT07029256 ·Status: RECRUITING

Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy

NCT02345473 ·Status: COMPLETED

MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer

NCT02735512 ·Status: TERMINATED

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

NCT06870253 ·Status: ACTIVE_NOT_RECRUITING

Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy

NCT04256122 ·Status: UNKNOWN

Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer

NCT00052637 ·Status: COMPLETED ·Phase: PHASE3

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

NCT06289270 ·Status: RECRUITING

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

NCT00867620 ·Status: UNKNOWN

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

NCT06167356 ·Status: RECRUITING

Cystoscopic Imaging Collection and Enhancement pROject

NCT02427321 ·Status: COMPLETED

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

NCT06193941 ·Status: COMPLETED

Biomarker Discovery and Application in Bladder Cancer

NCT00962052 ·Status: UNKNOWN

Urine Omics Predicting IO Therapy Responses in mUC Patients

NCT04641936 ·Status: RECRUITING

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

NCT06235853 ·Status: COMPLETED

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

NCT07048496 ·Status: RECRUITING ·Phase: NA

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

NCT05139134 ·Status: UNKNOWN

Biological Therapy in Treating Patients With Bladder Cancer

NCT00003779 ·Status: COMPLETED ·Phase: PHASE3

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

NCT03121768 ·Status: UNKNOWN

Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer

NCT00696579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project

NCT05357768 ·Status: RECRUITING

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

NCT06350734 ·Status: ACTIVE_NOT_RECRUITING

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

NCT06138561 ·Status: RECRUITING

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization

NCT04310813 ·Status: COMPLETED

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603 ·Status: RECRUITING ·Phase: NA